Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
09/29/1995 | CA2145579A1 Eva-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
09/28/1995 | WO1995025809A1 Compacted nucleic acids and their delivery to cells |
09/28/1995 | WO1995025808A1 Process for treating eucaryotic cells |
09/28/1995 | WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
09/28/1995 | WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
09/28/1995 | WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
09/28/1995 | WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β) |
09/28/1995 | WO1995025764A1 Double-stranded derivative of polyoxyethylene-containing lipid |
09/28/1995 | WO1995025763A1 Branched polyoxaalkyl macromolecules, process for making them and their uses |
09/28/1995 | WO1995025546A1 Dispensing unit containing a particulate product for the administration of drugs or nutrient preparations to animals and process for the manufacture of the particulate product |
09/28/1995 | WO1995025545A1 The use of dimeticone as a transport and carrier system and/or drug delivery system |
09/28/1995 | WO1995025544A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | WO1995025534A1 Stabilized composition for oral administration of peptides |
09/28/1995 | WO1995025523A1 Novel pharmaceutical composition for skin diseases |
09/28/1995 | WO1995025516A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant |
09/28/1995 | WO1995025513A1 Zinc compound and cyclodextrine for treatment of gastric disorders |
09/28/1995 | WO1995025507A1 Retinal-containing composition |
09/28/1995 | WO1995025505A1 Hydrophobic drug delivery systems |
09/28/1995 | WO1995025504A1 Emulsified drug delivery systems |
09/28/1995 | WO1995025502A1 Polyglycerine polyricinoleates |
09/28/1995 | WO1995023586A3 Cosmetic and/or pharmaceutical preparations |
09/28/1995 | DE19510551A1 Oral insulin prepns resistant to proteolytic enzymes |
09/28/1995 | CA2186045A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | CA2185882A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
09/28/1995 | CA2185647A1 Branched polyoxaalkyl macromolecules, process for making them and their uses |
09/28/1995 | CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf) |
09/28/1995 | CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.) |
09/28/1995 | CA2184200A1 Recombinant viruses, preparation and use in genic therapy |
09/28/1995 | CA2183647A1 Process for treating eucaryotic cells |
09/27/1995 | EP0673649A1 Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration |
09/27/1995 | EP0673648A1 Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate |
09/27/1995 | EP0673259A1 A method for transplanting cells into the brain and therapeutic uses therefor |
09/27/1995 | EP0673258A1 Polymer-bound camptothecin derivatives |
09/27/1995 | EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same. |
09/27/1995 | EP0673240A1 Stabilized medicinal aerosol solution formulations |
09/27/1995 | EP0673199A1 Stabilized lanthionine bacteriocin compositions |
09/27/1995 | EP0578768B1 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
09/27/1995 | EP0261225B1 Lectin complex and method and probe for making same |
09/27/1995 | CN1108968A Use of ion exchange resins loaded with quioolonecarboxylic acid derivatives |
09/27/1995 | CN1108931A Rapamycin formulations for oral administration |
09/27/1995 | CN1108927A Silica ketoconazole ointment and its preparation |
09/26/1995 | US5453447 Preparation of stable injectable β-carotene solubilizates |
09/26/1995 | US5453425 Risperidone oral formulation |
09/26/1995 | US5453373 Protein C derivatives |
09/26/1995 | US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
09/26/1995 | US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
09/26/1995 | US5453279 Enhancing transdermal absorption compositions; transdermal dosage form; and process |
09/23/1995 | CA2142940A1 Method and composition having enhanced alpha-hydroxy skin permeation and retention |
09/22/1995 | EP0681572A4 Cyclic imide thione activated polyalkylene oxides. |
09/21/1995 | WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
09/21/1995 | WO1995025121A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
09/21/1995 | WO1995025119A1 Stabilization of peptides and proteins for radiopharmaceutical use |
09/21/1995 | WO1995025084A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
09/21/1995 | WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy |
09/21/1995 | WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
09/21/1995 | WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
09/21/1995 | WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
09/21/1995 | WO1995024898A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
09/21/1995 | WO1995024893A1 Delivery systems for hydrophobic drugs |
09/21/1995 | WO1995024892A1 Aerosol drug formulations containing vitamin e |
09/21/1995 | WO1995024891A1 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions |
09/21/1995 | WO1995024890A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
09/21/1995 | WO1995022974A3 Film coated tablet of paracetamol and domperidone |
09/21/1995 | DE4410637C1 Injizierbare Lösungen von Dirithromycin Injectable solutions of dirithromycin |
09/21/1995 | DE4409357A1 Verwendung von Dimeticon zur Behandlung von Helicobacter Pylori-assoziierten Erkrankungen Use of dimethicone for the treatment of Helicobacter pylori associated diseases |
09/21/1995 | CA2185690A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
09/21/1995 | CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders |
09/21/1995 | CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
09/21/1995 | CA2185433A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
09/21/1995 | CA2184753A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents |
09/21/1995 | CA2183557A1 Aerosol drug formulations containing vitamin e |
09/20/1995 | EP0672682A1 hPTH(1-36) peptides, their preparation and pharmaceutical compositions |
09/20/1995 | EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use |
09/20/1995 | EP0672422A1 Antiinflammatory and analgesic transdermal gel |
09/20/1995 | EP0672414A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
09/20/1995 | EP0672410A1 Silicon vesicles and entrapment |
09/20/1995 | EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
09/20/1995 | EP0672076A1 Use of cationic polyurethanes and polycarbamides as auxiliary substances in cosmetic and pharmaceutical compositions. |
09/20/1995 | EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor |
09/20/1995 | EP0672053A1 Treatment of septic shock with conjugated biologically active peptides |
09/20/1995 | EP0671942A1 Medical use, a medical method and a pharmaceutical preparation |
09/20/1995 | EP0671937A1 Pharmaceutical emulsion compositions |
09/20/1995 | EP0671936A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-$g(a) FUNCTION |
09/20/1995 | EP0671929A1 Compositions |
09/20/1995 | EP0671919A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
09/20/1995 | EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
09/20/1995 | EP0671912A1 Injectable taxane derivative based compositions |
09/20/1995 | EP0671908A1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers |
09/20/1995 | EP0671906A1 Bioadhesive microspheres and their use as drug delivery and imaging systems |
09/20/1995 | EP0671905A1 Stable protein: phospholipid compositions and methods |
09/20/1995 | EP0671904A1 Antibiotic formulation and use for drug resistant infections |
09/20/1995 | EP0671903A1 Topical and transdermal delivery system utilizing submicron oil spheres |
09/20/1995 | EP0620731B1 Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it |
09/20/1995 | EP0584315B1 Cosmetic and/or pharmaceutical composition containing a dispersion of lipidic vesicles, process for the preparation of said dispersion, and lipidic vesicle dispersion |
09/20/1995 | EP0565620B1 Mitotoxin for treatment of vascular injury |
09/20/1995 | EP0536343B1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
09/20/1995 | EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus |
09/20/1995 | EP0429644B1 Chelating agents for attaching metal ions to proteins |
09/20/1995 | CN1108529A Rapamycin formulations for oral administration |
09/20/1995 | CN1029770C Controlled release bases for pharmaceuticals |